has shown encouraging direction, which needs to be evaluated further.”According to the researchers, applicability of the bio-engineered constructs was tested by transplanting the constructs in Wister rats.Khan said: “All the animals survived the entire duration of the study (14 days post-transplantation) which revealed that these constructs are immune-compatible.” They conclude that the engineered neuronal constructs, being natural biological scaffolds, were well tolerated by the host and may serve “as one of the potential options” for regenerating the neuronal connections damaged by SCI.”Further preclinical testing and optimisation of this approach in animal models will likely provide a more authentic road map for approaches for its future clinical applicability,” says their report.
